$455 Million is the total value of SABBY MANAGEMENT, LLC's 124 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 126.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | SPDR S&P 500 ETFput | $108,215,000 | -7.5% | 4,330 | +7.6% | 23.81% | +59.0% | |
| New | ISHARES RUSSELL 2000put | $57,577,000 | – | 4,300 | +100.0% | 12.67% | – | |
| Buy | ESPERION THERAPEUTICS INCput | $38,948,000 | +31.2% | 8,467 | +26.5% | 8.57% | +125.5% | |
| BIIB | Buy | BIOGEN INC | $37,908,000 | +201.9% | 125,975 | +254.5% | 8.34% | +418.9% |
| Buy | SPDR S&P BIOTECHput | $23,096,000 | +346.1% | 3,219 | +496.1% | 5.08% | +667.5% | |
| ESPR | Buy | ESPERION THERAPEUTICS INC | $6,392,000 | +43.5% | 138,958 | +38.4% | 1.41% | +146.7% |
| XBI | New | SPDR S&P BIOTECHetf | $4,468,000 | – | 62,266 | +100.0% | 0.98% | – |
| Buy | AMARIN CORPORATION PLCput | $3,736,000 | +351.2% | 2,745 | +439.3% | 0.82% | +675.5% | |
| BCLI | Buy | BRAINSTORM CELL THERAPEUTICS INC | $3,588,000 | +3.5% | 1,010,682 | +11.4% | 0.79% | +78.1% |
| ORMP | Buy | ORAMED PHARMACEUTICALS INC | $2,799,000 | -27.8% | 933,050 | +16.5% | 0.62% | +24.2% |
| OPHT | Buy | OPHTHOTECH CORP | $2,445,000 | -36.0% | 2,037,460 | +25.9% | 0.54% | +10.0% |
| VBLT | Buy | VASCULAR BIOGENICS LTD | $2,302,000 | -33.4% | 2,373,203 | +11.6% | 0.51% | +14.5% |
| Buy | NEKTAR THERAPEUTICScall | $2,137,000 | -40.8% | 650 | +9.8% | 0.47% | +1.7% | |
| FGEN | Buy | FIBROGEN INC | $2,102,000 | +187.9% | 45,417 | +277.9% | 0.46% | +396.8% |
| OTLK | New | OUTLOOK THERAPEUTICS INC | $1,393,000 | – | 2,786,448 | +100.0% | 0.31% | – |
| PAVMZ | Buy | PAVMED INC*w | $1,255,000 | +37.2% | 3,923,204 | +101.5% | 0.28% | +135.9% |
| AMRN | New | AMARIN CORPORATION PLCadr | $1,157,000 | – | 85,038 | +100.0% | 0.26% | – |
| SGMO | New | SANGAMO THERAPEUTICS INCput | $946,000 | – | 824 | +100.0% | 0.21% | – |
| New | SANGAMO THERAPEUTICS INC | $932,000 | – | 81,161 | +100.0% | 0.20% | – | |
| GNPX | Buy | GENPREX INC | $915,000 | -45.0% | 832,244 | +13.5% | 0.20% | -5.6% |
| New | BIOGEN INCcall | $903,000 | – | 30 | +100.0% | 0.20% | – | |
| CYTR | Buy | CYTRX CORP | $833,000 | -37.5% | 1,855,879 | +46.2% | 0.18% | +7.0% |
| ABILF | New | ABILITY INC | $680,000 | – | 357,974 | +100.0% | 0.15% | – |
| ISR | Buy | ISORAY INC | $676,000 | -32.3% | 2,254,829 | +17.1% | 0.15% | +16.4% |
| TNXP | New | TONIX PHARMACEUTICALS HLDG | $653,000 | – | 296,727 | +100.0% | 0.14% | – |
| AQB | New | AQUABOUNTY TECHNOLOGIES INC | $649,000 | – | 316,654 | +100.0% | 0.14% | – |
| SYN | New | SYNTHETIC BIOLOGICS INC | $626,000 | – | 1,117,459 | +100.0% | 0.14% | – |
| MKGI | Buy | MONAKER GROUP INC | $613,000 | -35.9% | 510,426 | +14.8% | 0.14% | +10.7% |
| MGTA | Buy | MAGENTA THERAPEUTICS INC | $611,000 | -46.0% | 107,156 | +13.7% | 0.13% | -7.6% |
| New | REWALK ROBOTICS LTD | $569,000 | – | 3,267,652 | +100.0% | 0.12% | – | |
| New | VIKING THERAPEUTICS INC | $555,000 | – | 72,500 | +100.0% | 0.12% | – | |
| PHIO | New | PHIO PHARMACEUTICALS | $520,000 | – | 1,575,157 | +100.0% | 0.11% | – |
| ATOS | Buy | ATOSSA GENETICS INC | $513,000 | -37.0% | 502,448 | +8.0% | 0.11% | +8.7% |
| EYEN | Buy | EYENOVIA INC | $505,000 | -23.1% | 177,110 | +8.4% | 0.11% | +32.1% |
| NURO | Buy | NEUROMETRIX INC | $505,000 | +1.8% | 664,177 | +78.1% | 0.11% | +76.2% |
| CUR | New | NEURALSTEM INC | $490,000 | – | 1,558,145 | +100.0% | 0.11% | – |
| ALT | New | ALTIMMUNE INC | $490,000 | – | 237,921 | +100.0% | 0.11% | – |
| DMPI | New | DELMAR PHARMACEUTICALS INC | $488,000 | – | 1,410,178 | +100.0% | 0.11% | – |
| IPCIF | New | INTELLIPHARMACEUTICS INTL INC | $469,000 | – | 1,944,978 | +100.0% | 0.10% | – |
| SCON | Buy | SUPERCONDUCTOR TECHNOLOGIES | $421,000 | -21.0% | 326,288 | +13.3% | 0.09% | +36.8% |
| AYTU | Buy | AYTU BIOSCIENCE INC | $408,000 | +316.3% | 515,002 | +1352.1% | 0.09% | +592.3% |
| HTBX | New | HEAT BIOLOGICS INC | $384,000 | – | 391,985 | +100.0% | 0.08% | – |
| SNOA | New | SONOMA PHARMACEUTICALS INC | $331,000 | – | 465,000 | +100.0% | 0.07% | – |
| OPGN | Buy | OPGEN INC COM NEW | $326,000 | +858.8% | 251,095 | +1380.7% | 0.07% | +1700.0% |
| JAGX | New | JAGUAR HEALTH INC | $300,000 | – | 1,311,580 | +100.0% | 0.07% | – |
| Buy | SESEN BIO INCput | $260,000 | -33.7% | 1,830 | +0.4% | 0.06% | +14.0% | |
| ACST | New | ACASTI PHARMA INCcl a | $229,000 | – | 275,000 | +100.0% | 0.05% | – |
| SOLO | New | ELECTRAMECCANICA VEHICLES CORP | $213,000 | – | 200,000 | +100.0% | 0.05% | – |
| RTTR | Buy | RITTER PHARMACEUTICALS INC | $206,000 | +10.8% | 343,642 | +243.6% | 0.04% | +87.5% |
| RSLS | Buy | RESHAPE LIFESCIENCES INC | $187,000 | +835.0% | 732,648 | +58.7% | 0.04% | +1266.7% |
| BLIN | New | BRIDGELINE DIGITAL INC | $180,000 | – | 778,983 | +100.0% | 0.04% | – |
| Buy | OPHTHOTECH CORPcall | $173,000 | -39.7% | 1,438 | +18.2% | 0.04% | +2.7% | |
| SNSS | Buy | SUNESIS PHARMACEUTICALS INC | $166,000 | -70.1% | 400,140 | +43.8% | 0.04% | -47.9% |
| APHB | New | AMPLIPHI BIOSCIENCES CORP | $168,000 | – | 816,095 | +100.0% | 0.04% | – |
| Buy | MICROBOT MED INC | $150,000 | -63.0% | 87,243 | +60.0% | 0.03% | -36.5% | |
| New | ALTIMMUNE INCput | $139,000 | – | 673 | +100.0% | 0.03% | – | |
| New | TENAX THERAPEUTICS INC | $131,000 | – | 108,427 | +100.0% | 0.03% | – | |
| New | LM FDG AMER INC | $117,000 | – | 98,927 | +100.0% | 0.03% | – | |
| ONTX | New | ONCONOVA THERAPEUTICS INC | $101,000 | – | 47,794 | +100.0% | 0.02% | – |
| CVM | Buy | CEL-SCI CORP | $93,000 | -7.9% | 32,256 | +30.0% | 0.02% | +53.8% |
| MOSY | New | MOSYS INC | $66,000 | – | 398,408 | +100.0% | 0.02% | – |
| FCSC | New | FIBROCELL SCIENCE INC | $64,000 | – | 42,400 | +100.0% | 0.01% | – |
| New | MANNKIND CORPcall | $48,000 | – | 449 | +100.0% | 0.01% | – | |
| Buy | SUNESIS PHARMACEUTICALS INCcall | $47,000 | -75.4% | 1,141 | +19.5% | 0.01% | -58.3% | |
| CRMD | New | CORMEDIX INC | $40,000 | – | 30,661 | +100.0% | 0.01% | – |
| Buy | CORMEDIX INCput | $41,000 | +46.4% | 305 | +6.3% | 0.01% | +125.0% | |
| New | CEL-SCI CORPput | $32,000 | – | 110 | +100.0% | 0.01% | – | |
| AVGR | New | AVINGER INC | $34,000 | – | 112,270 | +100.0% | 0.01% | – |
| OTLKW | New | OUTLOOK THERAPEUTICS INC*w | $27,000 | – | 177,439 | +100.0% | 0.01% | – |
| CTXR | Buy | CITIUS PHARMACEUTICALS INC | $29,000 | +45.0% | 28,045 | +142.5% | 0.01% | +100.0% |
| APDN | New | APPLIED DNA SCIENCES INC | $24,000 | – | 60,835 | +100.0% | 0.01% | – |
| FCEL | New | FUELCELL ENERGY INC | $20,000 | – | 37,110 | +100.0% | 0.00% | – |
| CLSN | New | CELSION CORPORATION | $15,000 | – | 10,843 | +100.0% | 0.00% | – |
| MNKD | New | MANNKIND CORP | $14,000 | – | 12,797 | +100.0% | 0.00% | – |
| SPHS | New | SOPHIRIS BIO INC | $10,000 | – | 12,046 | +100.0% | 0.00% | – |
| PHIOW | New | PHIO PHARMACEUTICALS*w | $5,000 | – | 194,959 | +100.0% | 0.00% | – |
| SRNE | New | SORRENTO TECH INC | $0 | – | 84,536 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TRUST UNIT | 37 | Q3 2023 | 49.1% |
| ISHARES TR | 35 | Q3 2023 | 52.2% |
| SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
| AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
| BIOGEN INC | 24 | Q1 2021 | 26.2% |
| SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
| BIOGEN INC | 23 | Q1 2021 | 13.7% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
| BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
| VERTEX PHARMACEUTICALS INC | 20 | Q1 2018 | 12.6% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AGM GROUP HOLDINGS, INC. | January 10, 2023 | 627,936 | 2.6% |
| Bit Digital, Inc | January 10, 2023 | 3,166,917 | 3.8% |
| Cingulate Inc. | January 10, 2023 | 10 | 5.0% |
| Context Therapeutics Inc. | January 10, 2023 | 796,706 | 5.0% |
| HeartBeam, Inc. | January 10, 2023 | 271,788 | 3.4% |
| PharmaCyte Biotech, Inc. | January 10, 2023 | 934,456 | 5.0% |
| Rebus Holdings, Inc.Sold out | January 10, 2023 | 0 | 0.0% |
| TANTECH HOLDINGS LTD | January 10, 2023 | 41,500 | 0.6% |
| Quanergy Systems, Inc. | January 04, 2023 | 936,905 | 5.8% |
| TuanChe Ltd | January 04, 2023 | 2,384,713 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.